X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis - sprookjes - yvandenbroek - TriplyDB

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

http://www.wikidata.org/entity/Q30495036

about

Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications.Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment.1,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?

P2860

Q36360389-A2ECAA1D-2D6D-4ED7-B857-61A220F52FDD Q37958645-82E3EBFA-F1DD-40B1-9B92-0F6621B3F1B4 Q38879138-EF533E39-68DC-4F65-BD1B-49F4BA7890E3

P2860

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

http://www.wikidata.org/entity/Q30495036

description

1990 nî lūn-bûn

@nan

1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@ast

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@en

type

label

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@ast

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@en

prefLabel

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@ast

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@en

P1433

Q30495036-DE05B95C-E853-4091-B00B-5AFDFBE9F827

P1476

Q30495036-F6CE1D76-BAAF-4584-9DC0-58503E3681AC

P2093

Q30495036-8D136A7A-0A5E-43BF-BA3E-CD7271F4E8BF

Q30495036-A30D0D60-99D7-4F34-9A1D-673456DECE59

Q30495036-C7E61EFD-D317-4BE7-AD19-40887B4C4C3E

Q30495036-C95A3ADE-016B-45EA-B599-F96578529A7F

Q30495036-D0D3D7B1-8771-48F2-9BDE-F9BFAEED539E

Q30495036-D131BD49-AF49-4A01-BBE7-A2A5E97C92E9

P2860

Q30495036-084BD1FF-761F-42BD-94E0-FC427A01C990

Q30495036-1F6B52FB-D3AD-4D0C-97FA-4267C3574820

Q30495036-272A64F5-159B-4EEB-9816-240B5D60E112

Q30495036-2FBE2AA2-0692-4CFF-A49F-5F3A8C35CCD6

Q30495036-475E2F4A-F50C-43E2-BB9D-C373F891FED7

Q30495036-5A4984CC-3F81-4E9A-A23F-959A0BDFE3D3

Q30495036-67E4D619-27D9-4971-A762-2817A32F604C

Q30495036-6F6190FB-8E41-4633-9E0E-CF9533F08A7E

Q30495036-70E5CE29-12EF-431C-B25C-AB5895AB9607

Q30495036-831FB2E9-5AA4-4D1B-A067-6F15952DB127

P304

Q30495036-7D66DD31-EC4F-4C48-8FCD-33E995090C82

P31

Q30495036-4AE38FC9-9C74-4E09-9D20-4FDB257BC8AB

P356

Q30495036-1906C968-97D3-4A09-805E-9C6CB549073E

P407

Q30495036-E3AAF13D-AE37-4554-ADDF-DB9FD1AE319A

P433

Q30495036-8E845896-FEC1-4E67-8E90-F1C7BA270FE8

P478

Q30495036-A606CBA2-0B02-4CB3-BDC6-64D4F124D3AA

P577

Q30495036-06266293-C69B-485B-B1C9-198D4BDE1598

P5875

Q30495036-ED3B8E13-D65F-4C9C-B24E-1B2256062A08

P698

Q30495036-95EEE01C-F0A7-4E4D-8DAA-696536C7A606

P932

Q30495036-A0F3E677-B58C-4D78-BF67-345E8F13A162

P356

P1433

Archives of Disease in Childhood

P1476

X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis

@en

P2093

Brodehl J

http://www.w3.org/2001/XMLSchema#string

Ehrich JH

http://www.w3.org/2001/XMLSchema#string

Hoyer PF

http://www.w3.org/2001/XMLSchema#string

Krohn HP

http://www.w3.org/2001/XMLSchema#string

Lucas M

http://www.w3.org/2001/XMLSchema#string

Reusz GS

http://www.w3.org/2001/XMLSchema#string

P2860

Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite.

Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets.

Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.

Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.

Vitamin D-resistant rickets: clinical experience with 41 typical familial hypophosphatemic patients and 2 atypical nonfamilial cases.

Hypophosphataemic rickets: final height and clinical symptoms in adults.

Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.

Growth disturbance in hereditary hypophosphatemia.

Reference values for urinary calcium excretion and screening for hypercalciuria in children and adolescents.

Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.

P304

1125-1128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.65.10.1125

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

1990-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20906575

http://www.w3.org/2001/XMLSchema#string

P698

2248503

http://www.w3.org/2001/XMLSchema#string

P932

1792379

http://www.w3.org/2001/XMLSchema#string